share_log

港股高开0.49%,青蒿素概念股表现强势

Hong Kong stocks opened 0.49% higher, and artemisinin concept stocks showed strong performance

富途资讯 ·  Jun 17, 2019 09:28

The Hong Kong stock market rebounded slightly last week, and the Hang Seng Index rose 0.57% weekly. European and American stock markets collectively closed down last Friday, and the US pet retailer Chewy surged 59% on the first day of listing. According to the news, the central bank has increased rediscounting and standing loan facilities by 300 billion yuan to strengthen liquidity support for small and medium-sized banks.

Opening today, major stock indexes opened higher, and the Hang Seng Index rose 0.49% to 27252.45 points. The national index rose 0.21% to 10442.06 points. Pre-market transactions on the Main Board amounted to HK$2,018 million. Judging from sector performance, new energy batteries and biotechnology registered the highest gains, while domestic insurance stocks, pharmaceuticals, automobiles, and mobile game stocks rose slightly, while steel stocks fell the most.

In terms of individual stocks, Geely Automobile led blue-chip stocks 1.64% higher; AIA, Zhongsheng Pharmaceutical, CNOOC, and Chuangke Industrial rose more than 1%; Tencent opened slightly higher; Hengan International opened 2% lower as the worst blue-chip stock; BYD rose nearly 2% to lead the national index; “artemisinin concept stocks”$Fosun Pharmaceuticals (02196.HK) $It opened 3.46% higher as the best Hong Kong stock. Another concept stock$Baiyun Mountain (00874.HK) $Up 0.61%.

According to the morning news, after years of hard work, Tu Yingyi and his team have achieved new breakthroughs in “antimalarial mechanism research”, “drug resistance factors” and “adjustment of treatment methods”. They have recently proposed practical treatment plans to address the “artemisinin resistance” problem, and have made new progress in “artemisinin treatment of lupus erythematosus and other indications” and “going global with traditional Chinese medicine research papers”, which have been highly recognized by the World Health Organization and authoritative experts at home and abroad.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment